Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 4, 1995 - Issue 4
Submit an article Journal homepage
8
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Monthly Update—Anti-infectives: New Drugs for the Treatment of Mycobacterial Infections

Ms Marriott Glaxo Research and Development Limited, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, UK
Pages 349-351 | Published online: 03 Mar 2008

References

  • HOUSTON S, FANNING A: Current and potential treatment of tuberculosis. Drugs (1994) 48:689–708.
  • ST GEORGIEV V: Treatment and developmental thera-?peutics of Mycobacterium avium complex (MAC) infec-tions. Int.J. Antimicmb. Agents (1994) 4:247–270.
  • MADDDC DS, TALLIAN KB, MEAD PS: Rifabutin: A review with emphasis on its role in the prevention of dissemi-nated Mycobacterium avium complex infection. Ann. Pharmacother. (1994) 28:1250–1254.
  • INDERLIED CB, BERMUDEZ LE, BARBARA-BURNHAM L,WU M, YOUNG LS: In vitro and macrophage activity of KRM-1648 against the Mycobacterium avium complex infection. 33rd Interscience Conf. Antimicrob. Agents (1993). Abstract No. 69.
  • SANTO H, TOMIOKA H, SATO K, EMORI M, YOMONE T:In vitro antimycobacterial activities of newly synthe-sised benzoxazino-rifamycins. Antimicrob. Agents Chemother. (1991) 35:542–547.
  • YAMANE T, HASLINZUME T, YAMESKITA T, KONISKI E,HOSOE K: Synthesis and biological activity of 3'-hy-droxy-5'-aminobenzoxazino rifatnycin derivatives. Chem. Pharm. Bull. (1993) 41:148–155.
  • 'CLEMENS SP, GROSSI MA, CYNAMON MH: Activity of KRM-1648, a new benzoxazino rifatnycin, against My-cobacterium tuberculosis in a murine modeL Antimi-crob. Agents Chemother. (1994) 38:2245–2248.
  • YEW WW, PIDDOCK LJV, LI MSK, LYAN D, CHAN CY, CHENG AFB: In vitro activity of quinolones and macrolides against mycobacteria. J. Anti microb Chemother. (1994) 34:343–351.
  • RAPP RP, MCGANEY SA, GOODMAN NL, SHADDICK DJ: New macrolide antibiotics: usefulness in infections caused by mycobacteria other than Mycobacterium tuberculosis. Ann. Pharmacother. (1994) 28:1255–1263.
  • ONYYI CO, NIGHTINGALE CH, NICOLAN DP, QUINTILIANI R: Activities of liposome-encapsulated azithromycin and rifabutin compared with that of clarithromycin against Mycobacterium avium-intracellulare complex In human macrophages. Int. J. Antimicrob. Agents (1994) 4:281–289.
  • SEYDEL JK, SCHAPER KJ, RUSCH-GERDES S: Chemother-apy of TB: experimental drugs and combination ther-apy. Immunobiol. 191:569–577.
  • STANFORD JL, STANFORD CA: hamunotherapy of tuber-culosis with Mycobacterium vaccae NCTC 11659. Im-munobiol. (1994) 191:555–563.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.